TMCI
Companies
NASDAQ
Treace Medical Concepts Inc.
Health Care
$5.46
-$1.98 (-26.61%)
Price Chart
Overview
About TMCI
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.
Market Cap
$366.5M
Volume
3.7M
Avg. Volume
2.7M
P/E Ratio
-8.92
Dividend Yield
0.00%
Employees
299.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.15
Moderate Correlation
Volatility
High (0.82)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, TMCI shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$366.5M
Volume3.7M
P/E Ratio-8.92
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 9, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025